File JWaters MD 5-30-12 Presentation
-
Upload
putu-yayuk-widyani-wiradirani -
Category
Documents
-
view
216 -
download
0
Transcript of File JWaters MD 5-30-12 Presentation
-
7/26/2019 File JWaters MD 5-30-12 Presentation
1/50
Changing Landscape of Obstetrical
Hemorrhage
Jonathan H. Waters, MD
Professor of Anesthesiology and Bioengineering
Chief of Anesthesiology, Magee-Womens Hospital of University ofPittsburgh Medical Center
Medical Director, UPMC Total Blood Management Program
-
7/26/2019 File JWaters MD 5-30-12 Presentation
2/50
-
7/26/2019 File JWaters MD 5-30-12 Presentation
3/50
http://bloodjournal.hematologylibrary.org/content/112/7/2617/F5.large.jpg
Blundells Blood Gravitator
-
7/26/2019 File JWaters MD 5-30-12 Presentation
4/50
Is obstetrical hemorrhage a
problem worth addressing?
A. Mortality
B. Morbidity
-
7/26/2019 File JWaters MD 5-30-12 Presentation
5/50
Healthy People, 2010
www.cdc.gov
-
7/26/2019 File JWaters MD 5-30-12 Presentation
6/50
The Joint Commission Sentinel
Event Alert
-
7/26/2019 File JWaters MD 5-30-12 Presentation
7/50
Pregnancy-related deaths in the United States in 20062007
http://www.cdc.gov/reproductivehealth/MaternalInfantHealth/Pregnancy-relatedMortality.htm
-
7/26/2019 File JWaters MD 5-30-12 Presentation
8/50
-
7/26/2019 File JWaters MD 5-30-12 Presentation
9/50
Morbidity of Hemorrhage
-
7/26/2019 File JWaters MD 5-30-12 Presentation
10/50
Postpartum hemorrhage
associated morbidity
Disseminated intravascular coagulopathy (DIC)
Renal and hepatic failure
Acute respiratory distress syndrome
Sheehans Syndrome
-
7/26/2019 File JWaters MD 5-30-12 Presentation
11/50
Postpartum hemorrhage
associated morbidity
Iron deficiency
Iron deficiency anemia
Transfusion
-
7/26/2019 File JWaters MD 5-30-12 Presentation
12/50
Bodnar LM et al. Am J Obstet & Gynecol 2005;193:36-44
-
7/26/2019 File JWaters MD 5-30-12 Presentation
13/50
-
7/26/2019 File JWaters MD 5-30-12 Presentation
14/50
Complications of Transfusions
I. Infectious Complications VII. Delayed TransfusionReactions
II. Hemolytic TransfusionReactions
VIII. NonhemolyticTransfusion Reactions
III. Immunomodulation IX. Graft-vs-host Disease
IV. Storage Defects X. Febrile Reactions
V. Cost XI. Allergic Reactions
VI. Gene Transmission XII. HLA Sensitization
-
7/26/2019 File JWaters MD 5-30-12 Presentation
15/50http://www.cmqcc.org/resources/1484
-
7/26/2019 File JWaters MD 5-30-12 Presentation
16/50
-
7/26/2019 File JWaters MD 5-30-12 Presentation
17/50http://www.cmqcc.org/resources/1484
-
7/26/2019 File JWaters MD 5-30-12 Presentation
18/50
-
7/26/2019 File JWaters MD 5-30-12 Presentation
19/50
POSTPARTUM HEMORRHAGE PROTOCOL
Strategy for Managing PPH Anticipation
Identification of Risk Factors
Prevention / Preparation
Recognition Assessment
Accurate Estimation of Blood Loss
Identification of Cause Act
Postpartum Hemorrhage Protocol (PPHP)
Mobilization of Rapid Response Team
-
7/26/2019 File JWaters MD 5-30-12 Presentation
20/50
Admission Hemorrhage Risk FactorsLow (Type & Screen/Hgb) Medium (Type & Screen/Hgb) High (Type & Cross/CBC with
Plt)
No previous uterine incision Prior Cesarean birth(s) oruterine surgery (RR = 10.38)
Placenta previa, Low lyingplacenta (RR = 3.38)
Singleton Pregnancy (RR =
60.69)
> 5 previous vaginal births Suspected placenta accreta or
percreta
5 previous vaginal births Chorioamnionitis (RR = 2.56) Hgb < 10 and other risk factors
No known bleeding disorder History of PPH Active bleeding on admission
No history of PPH Large uterine fibroids Known coagulopathy (RR =
2.97)
Hypertensive disorder of
pregnancy (RR = 2.05)
Retained placenta
Overdistended uterus
(macrosomia, polyhydramnios,
etc) (RR = 1.63)
Uterine rupture
Obesity (RR = 1.43) Hgb < 8
-
7/26/2019 File JWaters MD 5-30-12 Presentation
21/50
POSTPARTUM HEMORRHAGE PROTOCOL
Strategy for Managing PPH
Anticipation Identification of Risk Factors
Prevention / Preparation Recognition
Assessment
Accurate Estimation of Blood Loss
Identification of Cause Act
Postpartum Hemorrhage Protocol (PPHP)
Mobilization of Rapid Response Team
-
7/26/2019 File JWaters MD 5-30-12 Presentation
22/50
POSTPARTUM HEMORRHAGE PROTOCOL
Assessment
Ongoing quantitative evaluation of blood loss
Peach pad Plaid cloth pad Blue Chux pad
250 mL loss 100 mL loss 150 mL loss
-
7/26/2019 File JWaters MD 5-30-12 Presentation
23/50
POSTPARTUM HEMORRHAGE PROTOCOL
Strategy for Managing PPH
Anticipation Identification of Risk Factors
Prevention / Preparation Recognition
Assessment
Accurate Estimation of Blood Loss
Identification of Cause Act
Postpartum Hemorrhage Protocol (PPHP)
Mobilization of Rapid Response Team
-
7/26/2019 File JWaters MD 5-30-12 Presentation
24/50
Obstetric Crisis Patient Safety
Initiative: Magee-Womens Hospital
Medical Emergency Team Paradigm applied toobstetric care
Condition O
Assemble necessary personnel with singlepage
Force interdisciplinary communication
Encourage early crisis recognition Encourage teamwork
-
7/26/2019 File JWaters MD 5-30-12 Presentation
25/50
Wiser
Obstetric Crisis Team Training Course
Course Format:
Web-based presentation
Pre-course survey
Pretest
Brief didactic session
3 full scale human simulation scenarios
Video-based debriefing
Post-course survey
-
7/26/2019 File JWaters MD 5-30-12 Presentation
26/50
-
7/26/2019 File JWaters MD 5-30-12 Presentation
27/50
Staff in room informed of bleeding? Anesthesia aware? Intra-op consultsneeded/requested?
Call for help: OR charge (1-2802), Generalist (1-2526), Triage (1-2679), MFM (2862),Anesthesia (1-4148 ), Gyn Onc (med-trak), Urogyn (Medtrak)
Initial resuscitation: IV access x2? IVF open with pressure bag? Cell saver on thefield? Warming patient?
Source of bleeding?
-Is the uterus atonic?-Are all uterotonics in the room (see chart)?
-Recheck uterus for retained tissue?
-Is the uterine incision (including angles) hemostatic? -Apex of extension visualized and hemostatic?
-Is a vaginal/cervical exam warranted?
-Bakri balloon? Compression sutures?
-Is a hysterectomy being considered? Is a hysterectomy tray in the room?
-Any concern for bladder/ureteral injury? Cysto available?
Assessment of hemorrhage:-Stat CBC, platelets, INR, fibrinogen drawn and sent? Are serial labs needed? TEG performed?
-EBL and pt hemodynamics discussed?
-Has the blood bank (4646) been notified? Massive transfusion protocol activated?
Recovery:Does this patient need an ICU bed? Has CCM been notified (1-2790)?
C-Section Hemorrhage
Triggers for
checklist
use:
-EBL
>1000cc
- A bleedingextension
identified
- Surgeon
calls for
uterotonics
Objective: Stop bleeding, maintain
hemodynamic stability, avoid coagulopathy
Call ADM
charge
Picklephone
1-2800
Anesthesia Hemorrhage Checklist
-
7/26/2019 File JWaters MD 5-30-12 Presentation
28/50
Call for help if major fluid resuscitation necessary
Reduce volatile agents and nitrous oxide if hypotensive
Maintain normothermia with a fluid warmer and forced air warming blanketConsider rapid transfusion device
Consider blood salvage device (COBE BRAT)
Ensure adequate IV access, consider CVP, surgical cannulation of abdominal vein if abdomen
open.
Consider aortic cross-clamping.
Consider Vigileo, arterial line and CVP for hemodynamic monitoring
Consider TEE for continued hypotensionMonitor hemoglobin, TEG, electrolytes, ABG at frequent intervals
Remember to normalize any hypocalcemia with supplemental CaCl2at 500-1000 mg doses
Maintain acid base status with volume resuscitation and NaHCO3
Consider Tranexamic Acid, 1 gm IV for continued bleeding and suspected fibrinolysis
Consider trauma pack or major transfusion protocol.
Consider interosseus drill if IV access problematic
Trauma Pack = 10 units of RBCs (uncross-matched Group O) available in 5 minutes
FFP is NOT included but the Transfusion Service Staff will ask if FFP is needed.
Massive Transfusion Protocol (RBC + PLASMA + PLTS)
Anesthesia Hemorrhage Checklist
Anesthesia Hemorrhage Checklist
-
7/26/2019 File JWaters MD 5-30-12 Presentation
29/50
Call for help if major fluid resuscitation necessary
Reduce volatile agents and nitrous oxide if hypotensive
Maintain normothermia with a fluid warmer and forced air warming blanketConsider rapid transfusion device
Consider blood salvage device (COBE BRAT)
Ensure adequate IV access, consider CVP, surgical cannulation of abdominal vein if abdomen
open.
Consider aortic cross-clamping.
Consider Vigileo, arterial line and CVP for hemodynamic monitoring
Consider TEE for continued hypotensionMonitor hemoglobin, TEG, electrolytes, ABG at frequent intervals
Remember to normalize any hypocalcemia with supplemental CaCl2at 500-1000 mg doses
Maintain acid base status with volume resuscitation and NaHCO3
Consider Tranexamic Acid, 1 gm IV for continued bleeding and suspected fibrinolysis
Consider trauma pack or major transfusion protocol.
Consider interosseus drill if IV access problematic
Trauma Pack = 10 units of RBCs (uncross-matched Group O) available in 5 minutes
FFP is NOT included but the Transfusion Service Staff will ask if FFP is needed.
Massive Transfusion Protocol (RBC + PLASMA + PLTS)
Anesthesia Hemorrhage Checklist
-
7/26/2019 File JWaters MD 5-30-12 Presentation
30/50
B tl A t t f i S t
-
7/26/2019 File JWaters MD 5-30-12 Presentation
31/50
Duncan SE et al. Ann Surg 1974;180:296-304
Bentley Autotransfusion System
-
7/26/2019 File JWaters MD 5-30-12 Presentation
32/50
-
7/26/2019 File JWaters MD 5-30-12 Presentation
33/50
Catling S, Joels L. IJOA 2005;112:131-2
-
7/26/2019 File JWaters MD 5-30-12 Presentation
34/50
Organizations recommending blood
salvage during the peripartum period
Confidential Enquiry into Maternal and Child
Health (UK) National Institute for Health and Clinical
Excellence (UK)
Obstetric Anesthetists Association (UK) Assoc. of Anaesthetists of Great Britain and
Ireland (UK)
Anesthesia Hemorrhage Checklist
-
7/26/2019 File JWaters MD 5-30-12 Presentation
35/50
Call for help if major fluid resuscitation necessary
Reduce volatile agents and nitrous oxide if hypotensive
Maintain normothermia with a fluid warmer and forced air warming blanketConsider rapid transfusion device
Consider blood salvage device (COBE BRAT)
Ensure adequate IV access, consider CVP, surgical cannulation of abdominal vein if
abdomen open.
Consider aortic cross-clamping.
Consider Vigileo, arterial line and CVP for hemodynamic monitoring
Consider TEE for continued hypotensionMonitor hemoglobin, TEG, electrolytes, ABG at frequent intervals
Remember to normalize any hypocalcemia with supplemental CaCl2at 500-1000 mg doses
Maintain acid base status with volume resuscitation and NaHCO3
Consider Tranexamic Acid, 1 gm IV for continued bleeding and suspected fibrinolysis
Consider trauma pack or major transfusion protocol.
Consider interosseus drill if IV access problematic
Trauma Pack = 10 units of RBCs (uncross-matched Group O) available in 5 minutes
FFP is NOT included but the Transfusion Service Staff will ask if FFP is needed.
Massive Transfusion Protocol (RBC + PLASMA + PLTS)
Anesthesia Hemorrhage Checklist
Interosseus Drill
-
7/26/2019 File JWaters MD 5-30-12 Presentation
36/50
Interosseus Drill
Anesthesia Hemorrhage Checklist
-
7/26/2019 File JWaters MD 5-30-12 Presentation
37/50
Call for help if major fluid resuscitation necessary
Reduce volatile agents and nitrous oxide if hypotensive
Maintain normothermia with a fluid warmer and forced air warming blanketConsider rapid transfusion device
Consider blood salvage device (COBE BRAT)
Ensure adequate IV access, consider CVP, surgical cannulation of abdominal vein if abdomen
open.
Consider aortic cross-clamping.
Consider Vigileo, arterial line and CVP for hemodynamic monitoring
Consider TEE for continued hypotensionMonitor hemoglobin, TEG, electrolytes, ABG at frequent intervals
Remember to normalize any hypocalcemia with supplemental CaCl2at 500-1000 mg doses
Maintain acid base status with volume resuscitation and NaHCO3
Consider Tranexamic Acid, 1 gm IV for continued bleeding and suspected fibrinolysis
Consider trauma pack or major transfusion protocol.
Consider interosseus drill if IV access problematic
Trauma Pack = 10 units of RBCs (uncross-matched Group O) available in 5 minutes
FFP is NOT included but the Transfusion Service Staff will ask if FFP is needed.
Massive Transfusion Protocol (RBC + PLASMA + PLTS)
Anesthesia Hemorrhage Checklist
-
7/26/2019 File JWaters MD 5-30-12 Presentation
38/50
Vigileo Flo-trac
LiDCO
Non-invasive Cardiac Output Monitors
Anesthesia Hemorrhage Checklist
-
7/26/2019 File JWaters MD 5-30-12 Presentation
39/50
Call for help if major fluid resuscitation necessary
Reduce volatile agents and nitrous oxide if hypotensive
Maintain normothermiawith a fluid warmer and forced air warming blanketConsider rapid transfusion device
Consider blood salvage device (COBE BRAT)
Ensure adequate IV access, consider CVP, surgical cannulation of abdominal vein if abdomen
open.
Consider aortic cross-clamping.
Consider Vigileo, arterial line and CVP for hemodynamic monitoring
Consider TEE for continued hypotensionMonitor hemoglobin, TEG, electrolytes, ABG at frequent intervals
Remember to normalize any hypocalcemia with supplemental CaCl2at 500-1000 mg doses
Maintain acid base status with volume resuscitation and NaHCO3
Consider Tranexamic Acid, 1 gm IV for continued bleeding and suspected fibrinolysis
Consider trauma pack or major transfusion protocol.
Consider interosseus drill if IV access problematic
Trauma Pack = 10 units of RBCs (uncross-matched Group O) available in 5 minutes
FFP is NOT included but the Transfusion Service Staff will ask if FFP is needed.
Massive Transfusion Protocol (RBC + PLASMA + PLTS)
Anesthesia Hemorrhage Checklist
-
7/26/2019 File JWaters MD 5-30-12 Presentation
40/50
Body Temperature ( C)
Effect of Body Temperature on Coagulation
Rohrer MJ, Natale AM. Crit Care Med1992;20:1402-5.
-
7/26/2019 File JWaters MD 5-30-12 Presentation
41/50
Meng et al. J. Trauma 2003;55:886
-
7/26/2019 File JWaters MD 5-30-12 Presentation
42/50
Probability of Life-Threatening Coagulopathy
increases wi th hypo tension and hypotherm ia
Clinical Status Conditional Probability ofdeveloping coagulopathy
No risk Factor 1%
Severe trauma>25 10%Severe trauma+ISS*Systolic BP
-
7/26/2019 File JWaters MD 5-30-12 Presentation
43/50
Point of Care Testing
-
7/26/2019 File JWaters MD 5-30-12 Presentation
44/50
Point of Care Testing
-
7/26/2019 File JWaters MD 5-30-12 Presentation
45/50
Near Care Testing
-
7/26/2019 File JWaters MD 5-30-12 Presentation
46/50
Nuttall GA et al. Anesthesiology 2001;94:773-81
Outcome with Algorithm and Point of care testing
-
7/26/2019 File JWaters MD 5-30-12 Presentation
47/50
Nuttall GA et al. Anesthesiology 2001;94:773-81
Outcome with Algorithm and Point of care testing
-
7/26/2019 File JWaters MD 5-30-12 Presentation
48/50
Process Measure
Obstetrical and Anesthesia Hemorrhage Checklist
Nominator: Checklist Use
Denominator: Number of OB hemorrhages
-
7/26/2019 File JWaters MD 5-30-12 Presentation
49/50
Outcome MeasurePercent of women transfused
The goal would be to reduce the percentage of womentransfused.
Numerator: Women who gave birth >=20 weeks gestation
and received 1 unit or > units of any blood product during
Denominator: All births
Average transfusion exposureThis would measure whether QI has reduced transfusion
exposure. This is important because the complications of
transfusion are dose related.
Numerator: total units transfused
Denominator: women transfused
-
7/26/2019 File JWaters MD 5-30-12 Presentation
50/50
Questions?
Jonathan Waters, M.D.